PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Pluri Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 10, 2026
$0.85−0.08 (-8.58%)
Close on Oct 19, 2026
- Market cap
- $9.08M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Pluri has not reported a dividend
No dividend per share appears in Pluri's annual filings since fiscal 2011.